Roivant Sciences (ROIV) Depreciation & Amortization (CF) (2021 - 2025)

Roivant Sciences' Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $2.7 million for Q4 2025.

• Quarterly Depreciation & Amortization (CF) fell 78.57% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $4.7 million (down 78.86% YoY) and the FY2026 annual result came in at $3.3 million, down 76.21% from the prior year.
• Depreciation & Amortization (CF) was $2.7 million for Q4 2025 at Roivant Sciences, up from $921000.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $16.8 million in Q4 2023 and bottomed at $921000.0 in Q3 2025.
• A 5-year average of $6.2 million and a median of $4.9 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 205.35% — and 2025, when it sank 80.98%.
• Roivant Sciences' Depreciation & Amortization (CF) stood at $4.2 million in 2021, then surged by 205.35% to $12.9 million in 2022, then soared by 30.28% to $16.8 million in 2023, then decreased by 24.78% to $12.6 million in 2024, then sank by 78.57% to $2.7 million in 2025.
• Business Quant data shows ROIV's Depreciation & Amortization (CF) at $2.7 million in Q4 2025, $921000.0 in Q3 2025, and $1.1 million in Q2 2025.